BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh

 You are in:  Business
Front Page 
UK Politics 
Market Data 
Your Money 
Business Basics 
Talking Point 
In Depth 

Commonwealth Games 2002

BBC Sport

BBC Weather

Wednesday, 13 March, 2002, 15:38 GMT
Indian drug maker buys UK firms
Dr Reddy logo
Dr Reddy is keen to expand into Europe
Indian drug maker Dr Reddy's has made its first overseas acquisition in a deal to buy two small British generic drug companies for 9m ($12.7m).

Dr Reddy's, India's only US-listed pharmaceutical company, said the acquisition of BMS Laboratories and its subsidiary Meridian Healthcare would be completed by early April.

Chief executive G V Prasad said the acquisition would "jumpstart" the company's generics business in the UK.

"This acquisition gives an entry for Dr Reddy into Europe, which it's been looking for for some time," Rusmik Oza, Mumbai-based brokerage Karvy Stock Broking told the BBC's World Business Report.

"It will be the platform for Dr Reddy to first increase sales in the UK and then in Europe."

British generics

The Hyderabad-based drug maker said the BMS group made solid and liquid medication and packaging.

In a statement it said Meridian currently sold 30 generic products and planned to get licences for another 70.

The BMS group made a profit of 1.6m on sales of 8million in 2001.

US market

Dr Reddy's main export market for its generic drugs is the US.

It has sold $60m worth of a generic copy of Eli Lilly's anti-depressant Prozac in the US.

Other Indian drug makers like Ranbaxy Laboratories, Wockhardt and Sun Pharmaceutical Industries have already made acquisitions in the US and Europe.

Rusmik Oza, Karvy Stock Broking
"It will be the platform for Dr Reddy to first increase sales in the UK and then in Europe."
See also:

08 Oct 01 | Business
African firm wins Aids drug permit
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Business stories are at the foot of the page.

E-mail this story to a friend

Links to more Business stories